H
Hideki Kawanishi
Researcher at Hiroshima University
Publications - 195
Citations - 4791
Hideki Kawanishi is an academic researcher from Hiroshima University. The author has contributed to research in topics: Peritoneal dialysis & Hemodialysis. The author has an hindex of 32, co-authored 179 publications receiving 4040 citations. Previous affiliations of Hideki Kawanishi include Fukushima Medical University.
Papers
More filters
Journal ArticleDOI
Encapsulating peritoneal sclerosis : Definition, etiology, diagnosis, and treatment
TL;DR: The most common term used in the nephrology literature in recent years has been sclerosing encapsulating peritonitis, but the popularity of the term does not necessarily validate its continued use, as it is marred by its morphologic inaccuracy.
Journal ArticleDOI
Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.
Hideki Kawanishi,Yoshindo Kawaguchi,Hiroyoshi Fukui,Shigeko Hara,Akio Imada,Hitoshi Kubo,Masao Kin,Masahiko Nakamoto,Seiji Ohira,Takao Shoji +9 more
TL;DR: It appears that PD can be continued successfully with an acceptable, low risk for EPS for at least 8 years, whereas stricter caution is required for patients receiving PD for longer periods.
Journal Article
Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.
TL;DR: It is the recommendation of the authors that EPS be adopted as the more appropriate term for encapsulating peritoneal sclerosis, and the best literal definition of EPS is based on clinical-pathologic criteria.
Journal ArticleDOI
Evaluation and management of ultrafiltration problems in peritoneal dialysis
Salim Mujais,Karl D. Nolph,Ram Gokal,Peter G. Blake,John Burkart,Gerald A. Coles,Yoshindo Kawaguchi,Hideki Kawanishi,Stephen M. Korbet,Raymond T. Krediet,Bengt Lindholm,Dimitrios G. Oreopoulos,Bengt Rippe,Rafael Selgas +13 more
TL;DR: Peritoneal dialysis (PD) has been considered an optimal approach to this therapeutic goal, avoiding fluctuant volume status and benefiting from better homeostatic stability as mentioned in this paper.
Journal ArticleDOI
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Christopher T. Chan,Peter J. Blankestijn,Laura M. Dember,Maurizio Gallieni,David Harris,Charmaine E. Lok,Rajnish Mehrotra,Paul E. Stevens,Angela Yee-Moon Wang,Michael Cheung,David C. Wheeler,Wolfgang C. Winkelmayer,Carol A. Pollock,Ali K. Abu-Alfa,Joanne M. Bargman,Anthony J. Bleyer,Edwina A. Brown,Andrew Davenport,Simon J. Davies,Frederic O. Finkelstein,Jennifer E. Flythe,Eric Goffin,Thomas A. Golper,Rafael Gomez,Takayuki Hamano,Manfred Hecking,Olof Heimbürger,Barnaby Hole,Daljit Hothi,T. Alp Ikizler,Yoshitaka Isaka,Kunitoshi Iseki,Vivekanand Jha,Hideki Kawanishi,Peter G. Kerr,Paul Komenda,Csaba P. Kovesdy,Ed Lacson,Maurice Laville,Jung Pyo Lee,Edgar V. Lerma,Nathan W. Levin,Monika Lichodziejewska-Niemierko,Adrian Liew,Elizabeth Lindley,Robert S. Lockridge,Magdalena Madero,Ziad A. Massy,Linda M. McCann,Klemens B. Meyer,Rachael L. Morton,Annie Claire Nadeau-Fredette,Hirokazu Okada,José Pérez,Jeff Perl,Kevan R. Polkinghorne,Miguel C. Riella,Bruce M. Robinson,Michael V. Rocco,Steven J. Rosansky,Joris I. Rotmans,María Fernanda Slon Roblero,Navdeep Tangri,Marcello Tonelli,Allison Tong,Yusuke Tsukamoto,Kriang Tungsanga,Tushar J. Vachharajani,Ismay van Loon,Suzanne Watnick,Daniel E. Weiner,Martin Wilkie,Elena Zakharova +72 more
TL;DR: The need to move away from a "one-size-fits-all" approach to dialysis and provide more individualized care that incorporates patient goals and preferences while still maintaining best practices for quality and safety is represented during the KDIGO conference.